INTEGRA LIFESCIENCES HOLDINGS CORP (IART) Net margin 2016–2025
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) net profit margin by fiscal year — reported net income divided by reported revenue.
-31.6%FY2025 · since FY2016: 7.5% → -31.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -31.6% | -31.2 pp |
| FY2024 | -0.4% | -4.8 pp |
| FY2023 | 4.4% | -7.2 pp |
| FY2022 | 11.6% | +0.6 pp |
| FY2021 | 11.0% | +1.2 pp |
| FY2020 | 9.8% | +6.5 pp |
| FY2019 | 3.3% | -0.8 pp |
| FY2018 | 4.1% | -1.3 pp |
| FY2017 | 5.4% | -2.1 pp |
| FY2016 | 7.5% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More IART financial trends
IART RevenueIART Net incomeIART Gross profitIART Gross marginIART Operating incomeIART Operating marginIART Operating cash flowIART Free cash flowIART Capital expendituresIART Return on equityIART Stock buybacksIART Dividends paidIART Total assetsIART Total liabilitiesIART Shareholders’ equityIART overview →